Alpha-1 Antitrypsin Deficiency: Are You Overlooking a Leading Genetic Culprit in Liver Disease?

This education program offers expert guidance on alpha-1 antitrypsin deficiency (AATD)–associated liver disease (LD), aiming to enhance HCPs’ knowledge in diagnosing and assessing AATD-LD. It targets hepatologists, gastroenterologists, and pulmonologists, with a secondary focus on primary care providers, nurse practitioners, physician associates, and pediatricians managing patients with AATD.

Share

Program Content

Activities

Screening for AATD-LD
Screening for Alpha-1 Antitrypsin Deficiency Liver Disease: Call to Action
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 28, 2024

Expires: August 27, 2025

Activities

AATD LD
Alpha-1 Antitrypsin Deficiency: Are You Overlooking a Leading Genetic Culprit in Liver Disease?
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 15, 2024

Expires: November 14, 2025

Faculty

cover img faculity

Mark Brantly, MD

Professor Emeritus
Department of Medicine
University of Florida College of Medicine
Gainesville, Florida

cover img faculity

Virginia Clark, MD, MS

Clinical Professor of Medicine
Division of Gastroenterology, Hepatology, & Nutrition
University of Florida College of Medicine
Gainesville, Florida

cover img faculity

Pavel Strnad, MD

Full Professor
Department of Internal Medicine III
University Hospital Aachen
Aachen, Germany

cover img faculity

Jeffrey Teckman, MD

Drs Patrician and James Endowed Chair
Professor of Pediatrics and Biochemistry and Molecular Biology
Vice Chair of Pediatrics
St Louis University School of Medicine
Cardinal Glennon Children’s Hospital
St Louis, Missouri

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Takeda Development Center Americas, Inc.

Takeda Development Center Americas, Inc.